DeepTI: A deep learning-based framework decoding tumor-immune interactions for precision immunotherapy in oncology.
Journal:
SLAS discovery : advancing life sciences R & D
PMID:
35058187
Abstract
BACKGROUND: Increasing evidence suggests the immunomodulatory potential of genes in oncology. But the identification of immune attributes of genes is costly and time-consuming, which leads to an urgent demand to develop a prediction model.